Mucosal adjuvant properties of the Shigella invasin complex.

Infection and Immunity
Robert W KaminskiEdwin V Oaks

Abstract

The Shigella invasin complex (Invaplex) is an effective mucosal vaccine capable of protecting against Shigella challenge in animal models. The major antigenic constituents of Invaplex are the Ipa proteins and lipopolysaccharide. The cell-binding capacity of the Ipa proteins prompted the investigation into the adjuvanticity of Invaplex. Using ovalbumin (OVA) as a model antigen, intranasal immunization with OVA combined with Invaplex was found to enhance anti-OVA serum immunoglobulin G (IgG) and IgA responses and induce OVA-specific mucosal antibody responses at sites located both proximal and distal to the immunization site. The immune responses induced with OVA and Invaplex were comparable in both magnitude and duration to the immune responses induced after immunization with OVA and cholera toxin. The OVA-specific immune response was characterized by high levels of serum IgG1 and increased production of interleukin-4 (IL-4), IL-5, or IL-10 from lymphoid cells of immunized animals, suggesting a Th2 response. In addition to enhancing the immunogenicity of OVA, Invaplex-specific immune responses were also induced, indicating the potential for the development of a combination vaccine consisting of Invaplex and other immunogens. Pre...Continue Reading

References

Jun 1, 1991·Microbiological Reviews·T L Hale
Jan 1, 1972·Transactions of the Royal Society of Tropical Medicine and Hygiene·E GanJ S Walker
Jan 1, 1995·Pharmaceutical Biotechnology·F R Vogel, M F Powell
Feb 1, 1993·Current Opinion in Immunology·J J Neefjes, F Momburg
Feb 1, 1995·The Journal of Experimental Medicine·C S HsiehK M Murphy
Dec 1, 1994·The Journal of Infectious Diseases·D N TaylorM H Sjogren
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·R MénardC Dehio
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Jun 22, 1999·The Journal of Experimental Medicine·T OhtekiS Koyasu
Oct 8, 1999·The Journal of Clinical Investigation·B L DickinsonW I Lencer
Nov 18, 2000·Infection and Immunity·K R TurbyfillE V Oaks
Feb 13, 2001·Immunology·E C LavelleD T O'Hagan
Aug 23, 2001·Advanced Drug Delivery Reviews·S S Davis
Oct 6, 2001·The New England Journal of Medicine·G Ada
Dec 18, 2002·The Journal of Experimental Medicine·Stephanie C EisenbarthKim Bottomly
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Prosper N BoyakaJerry R McGhee
Mar 26, 2003·Infection and Immunity·Christofer J Vindurampulle, Stephen R Attridge
Jul 23, 2003·Current Medicinal Chemistry·Zi-Hua Jiang, R Rao Koganty
Dec 6, 2003·American Journal of Respiratory Cell and Molecular Biology·Amanda MuirAlice Prince
Feb 21, 2004·FEMS Microbiology Reviews·Amy V Jennison, Naresh K Verma
Jul 6, 2004·Immunological Reviews·Bali Pulendran
Jul 24, 2004·Expert Review of Vaccines·Gideon Kersten, Hoang Hirschberg
Feb 1, 2005·Annals of the New York Academy of Sciences·Y CongC O Elson
Jan 15, 1982·Science·B L StrehlerL M Zatz

❮ Previous
Next ❯

Citations

Jun 5, 2013·Biologicals : Journal of the International Association of Biological Standardization·Mahdi HesarakiReza Ranjbar
Nov 4, 2009·Infection and Immunity·Ryan T RanalloMalabi M Venkatesan
Jan 15, 2014·Applied Microbiology and Biotechnology·James A Gregory, Stephen P Mayfield
Apr 16, 2013·Journal of Immunological Methods·Robert W KaminskiEdwin V Oaks
Dec 1, 2009·Expert Review of Vaccines·Robert W Kaminski, Edwin V Oaks
Apr 7, 2009·Expert Opinion on Biological Therapy·Sandra ChadwickMansoor Amiji
Aug 9, 2007·Expert Opinion on Drug Delivery·Dmytro S SilinAldar S Bourinbaiar
Jan 4, 2008·Journal of Drug Targeting·Bram SlütterWim Jiskoot
Sep 21, 2007·Expert Opinion on Drug Delivery·Gideon Kersten, Hoang Hirschberg
Nov 26, 2009·Advanced Drug Delivery Reviews·Sandra ChadwickMansoor Amiji
Jan 10, 2014·Clinical and Vaccine Immunology : CVI·R W KaminskiE V Oaks
Mar 7, 2014·Infection and Immunity·Michael GregoryEdwin V Oaks
Feb 20, 2009·Clinical and Vaccine Immunology : CVI·Robert W KaminskiEdwin V Oaks
Nov 1, 2006·World Journal of Gastroenterology : WJG·Amy V JennisonNaresh K Verma
Jul 3, 2021·Microorganisms·Richard WalkerLouis Bourgeois

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.